Invention Grant
- Patent Title: Compositions and methods of treating retinal disease
-
Application No.: US15861332Application Date: 2018-01-03
-
Publication No.: US10202348B2Publication Date: 2019-02-12
- Inventor: Thomas A. Jordan , John E. Dowling , John Clifford Chabala
- Applicant: Aldeyra Therapeutics, Inc.
- Applicant Address: US MA Lexington
- Assignee: Aldeyra Therapeutics, Inc.
- Current Assignee: Aldeyra Therapeutics, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Dechert LLP
- Agent Andrea L. C. Reid
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D215/38 ; A61K31/4418 ; A61K31/41 ; A61K31/423 ; A61K31/426 ; A61K31/435 ; A61K31/4706 ; C07C215/68 ; C07C229/56 ; C07C229/60 ; C07D277/40 ; C07D277/56 ; A61K31/47
Abstract:
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
Public/Granted literature
- US20180194733A1 COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE Public/Granted day:2018-07-12
Information query
